Halozyme Therapeutics, Inc. · NASDAQ:HALO
Connaughton Bernadette received 6,796 Halozyme Therapeutics, Inc. shares as an award (Form 4)
Traded May 5, 2026 · Filed May 7, 2026
On May 5, 2026, Connaughton Bernadette (Director) received 6,796 Halozyme Therapeutics, Inc. shares as an award, leaving 45,294 shares. Filed May 7, 2026 (Form 4).
- Awarded
- 6,796 shares
- Holding after
- 45,294 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Award | 6,796 | 45,294 | Direct |
Source
Related
- Halozyme Therapeutics, Inc.
- Connaughton Bernadette
- Halozyme Therapeutics, Inc. shareholders
- Form 4/A · Connaughton Bernadette · Oct 8, 2026
- Form 4 · Connaughton Bernadette · Aug 11, 2026
- Form 4 · Connaughton Bernadette · Jul 2, 2026
- Form 4 · Connaughton Bernadette · Jun 2, 2026
- Form 4 · Connaughton Bernadette · May 5, 2026
- Form 4 · Torley Helen · Oct 8, 2026
- Form 4 · Posard Matthew L. · Oct 2, 2026
- Form 4 · Daly James M · Oct 2, 2026
- Form 4 · Posard Matthew L. · Sep 17, 2026
- Form 4 · Torley Helen · Sep 11, 2026